Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 5;4(15):3520–3527. doi: 10.1182/bloodadvances.2020002335

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by The American Society of Hematology

PMC Copyright notice

Figure 1. — Residual DOAC levels according to preprocedural DOAC-interruption interval in hours. Patients undergoing low- and high-bleeding-risk procedures had their DOAC stopped 1 and 2 days prior to the procedure, respectively. Patients undergoing low-bleeding-risk procedures are indicated in black, whereas patients undergoing high-bleeding-risk procedures are indicated in blue. (A) The median preoperative-interruption intervals for low- and high-bleeding-risk procedures for apixaban were 39.4 hours (IQR, 37.5, 41.5) and 63.8 hours (IQR, 61.0, 67.0), respectively. (B) The median preoperative-interruption intervals for dabigatran for low- and high-bleeding-risk procedures were 40.5 (IQR, 38.4, 44.7) and 63.8 (IQR, 61.7, 74.3), respectively. (C) The median preoperative-interruption intervals for rivaroxaban for low- and high-bleeding-risk procedures were 48.0 (IQR, 40.8, 51.0) and 72.0 (IQR, 66.1, 75.0), respectively.